Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Daily Dosing of Busulfan in Allogeneic Hematopoietic Cell Transplantation Reduces Costs with Equivalent or Superior Outcomes Singhal, S., Kim, T. Y., Tierney, D., Rezvani, A. ELSEVIER SCIENCE INC. 2019
View details for Web of Science ID 000540655500272